Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Nneka N. Ufere"'
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 5, Pp 634-645 (2024)
Patients with cirrhosis frequently experience an unpredictable illness trajectory, with frequent hospitalizations and complications. Along with the uncertain nature of the disease, the possibility of a lifesaving and curative transplant often makes p
Externí odkaz:
https://doaj.org/article/0d9ad6f40ed341c195f4e88b86a149a0
Autor:
Robin Klein, Erin D. Snyder, Jennifer Koch, Anna Volerman, Sarah Alba-Nguyen, Katherine A. Julian, Vanessa Thompson, Nneka N. Ufere, Sherri-Ann M. Burnett-Bowie, Anshul Kumar, Bobbie Ann A. White, Yoon Soo Park, Kerri Palamara
Publikováno v:
BMC Medical Education, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Equitable assessment is critical in competency-based medical education. This study explores differences in key characteristics of qualitative assessments (i.e., narrative comments or assessment feedback) of internal medicine postg
Externí odkaz:
https://doaj.org/article/a5453a78c74744a89d1b05549e3384c6
Autor:
Maureen P. Whitsett, Nneka N. Ufere, Arpan Patel, Judy A. Shea, Christopher A. Jones, Oren K. Fix, Marina Serper
Publikováno v:
Hepatology Communications, Vol 6, Iss 7, Pp 1680-1688 (2022)
Abstract Despite the likely benefits of palliative care (PC) for patients with cirrhosis, physician experiences and perspectives about best practices are variable. We aimed to assess PC experience and gaps in training among transplant hepatology fell
Externí odkaz:
https://doaj.org/article/9b0db440531c4c8589c29bb591c04710
Publikováno v:
Hepatology Communications, Vol 7, Iss 1, Pp e0001-e0001 (2023)
Background:. Chronic liver disease (CLD) is associated with rising health care utilization and cost. We aimed to describe the frequency of cost/value (C/V) statements in CLD-related clinical guidance documents (CGDs). Methods:. CGD with a focus on CL
Externí odkaz:
https://doaj.org/article/f10d08988c02445fb6b624acd29cf8b5
Autor:
Arpan A. Patel, Christopher Woodrell, Nneka N. Ufere, Lissi Hansen, Puneeta Tandon, Manisha Verma, Jennifer Lai, Rachel Pinotti, Mina Rakoski, the Palliative Care Education, Advocacy, and Research in Liver Disease (PEARL) Workgroup and the AASLD Public Health / Healthcare Delivery Special Interest Group (SIG)
Publikováno v:
Hepatology Communications, Vol 5, Iss 9, Pp 1469-1480 (2021)
Individuals with advanced liver disease (AdvLD), such as decompensated cirrhosis (DC) and hepatocellular carcinoma (HCC), have significant palliative needs. However, little research is available to guide health care providers on how to improve key do
Externí odkaz:
https://doaj.org/article/e180b62e9df74c09a3adf796e86f718e
Autor:
A Sofia C Warner, Nneka N Ufere, Naomi J Patel, Emily S Lau, Amiko M Uchida, Kelsey Hills-Dunlap, Gabrielle K Bromberg, Elizabeth A Cunningham, Michelle D Tagerman, Gabrielle G Mills, Kerri Palamara, Nancy A Rigotti, Sherri-Ann M Burnett-Bowie, Doreen DeFaria Yeh, Varsha K Tanguturi
Publikováno v:
Postgraduate Medical Journal. 99:79-82
Women physicians are promoted less often, more likely to experience harassment and bias, and paid less than their male peers. Although many institutions have developed initiatives to help women physicians overcome these professional hurdles, few are
Publikováno v:
Gastroenterology. 164:171-176
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial
Autor:
Areej El‐Jawahri, Marlise R. Luskin, Joseph A. Greer, Lara Traeger, Mitchell Lavoie, Dagny Marie Vaughn, Stephanie Andrews, Daniel Yang, Kofi Y. Boateng, Richard A. Newcomb, Nneka N. Ufere, Amir T. Fathi, Gabriela Hobbs, Andrew Brunner, Gregory A. Abel, Richard M. Stone, Daniel J. DeAngelo, Martha Wadleigh, Jennifer S. Temel
Publikováno v:
Cancer. 129:1075-1084
Publikováno v:
The Lancet Gastroenterology & Hepatology. 8:106-108
Autor:
Hannah R. Abrams, Ryan D. Nipp, Lara Traeger, Mitchell W. Lavoie, Matthew J. Reynolds, Nneka N. Ufere, Annie C. Wang, Kofi Boateng, Thomas W. LeBlanc, Areej El-Jawahri
Publikováno v:
Blood Advances. 6:4208-4215
Patients with high-risk acute myeloid leukemia (AML) often experience intensive medical care at the end of life (EOL), including high rates of hospitalizations and intensive care unit (ICU) admissions. Despite this, studies examining code status tran